Pacer Advisors’s Transmedics TMDX Stock Holding History

Pacer Advisors’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$238K	Buy	2,391 +1,061	+80%	+$138K	﹤0.01%	1706
2025 Q4	$162K	Buy	+1,330	New	+$167K	﹤0.01%	2173

Other funds holding TMDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pacer Advisors's TMDX Position: Q1 2026 in Review

Pacer Advisors increased its Transmedics (TMDX) stake by 80% in Q1 2026, buying an estimated $138K and bringing the position to 2,391 shares worth $238K. The position accounts for ﹤0.01% of the portfolio, ranked #1706.

Pacer Advisors first reported a position in TMDX in Q4 2025 and has held it in 2 quarters since. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

Pacer Advisors held 2,391 shares of Transmedics worth $238K as of Q1 2026.
Pacer Advisors bought 1,061 Transmedics shares in Q1 2026, an estimated $138K.
Transmedics made up ﹤0.01% of Pacer Advisors's portfolio in Q1 2026, its #1706 holding.
Pacer Advisors first reported a position in Transmedics in Q4 2025 and has held it in 2 quarters since.
414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Pacer Advisors's 13F filing for Q1 2026, filed 6 May 2026.